Newsroom press releases

08/11/13 - 1:00

The Board of Directors approves the Q3'13 Results (766.57 KB)

Financial Data

Download

29/10/13 - 1:00

DiaSorin signes a 5-year agreement with Roche (432.42 KB)

Acquisition / Partnership

Download

25/10/13 - 2:00

DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)

Products Immunodiagnostic

Download

10/10/13 - 2:00

DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)

Products Immunodiagnostic

Download

24/09/13 - 2:00

DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)

Products Immunodiagnostic

Download

01/08/13 - 2:00

The Board of Directors approves the results for the H1 '13 (386.67 KB)

Financial Data

Download

24/07/13 - 2:00

DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)

Products

Download

11/07/13 - 2:00

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)

Products Immunodiagnostic

Download

28/06/13 - 2:00

DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)

Products Immunodiagnostic

Download

20/06/13 - 2:00

DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)

Products Immunodiagnostic

Download

10/05/13 - 2:00

The Board of Directors approves the results for Q1'13 (763.61 KB)

Financial Data

Download

02/05/13 - 2:00

Compensation Commitee-Errata corrige (179.38 KB)

Financial Data

Download

22/04/13 - 2:00

Shareholders' meeting approves FY Results 2012 (57.22 KB)

Financial Data

Download

17/04/13 - 2:00

FDA approves the Aldosterone assay (439.58 KB)

Products Immunodiagnostic

Download

02/04/13 - 2:00

DiaSorin signs an agreement with Seegene (243.64 KB)

Acquisition / Partnership

Download

08/03/13 - 1:00

The BoD approves FY 2012 results (477.24 KB)

Financial Data

Download

07/03/13 - 1:00

Notification of changes in share capital (46.86 KB)

Financial Data

Download

07/03/13 - 1:00

Notice availability By-Laws (36.87 KB)

Financial Data

Download

07/02/13 - 1:00

Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)

Products Immunodiagnostic

Download

07/02/13 - 1:00

Notification of changes in share capital (46.89 KB)

Financial Data

Download

07/02/13 - 1:00

Notice availability By-Laws (139.13 KB)

Financial Data

Download

30/01/13 - 1:00

The Board of Directors approves the results for the FY '12 (477.24 KB)

Financial Data

Download

29/01/13 - 1:00

Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)

Products Immunodiagnostic

Download

24/12/09 - 1:00

Financial instruments to employees (26.76 KB)

Financial Data

Download

30/10/09 - 1:00

The BoD approves Q3'09 results (212.92 KB)

Financial Data

Download

12/10/09 - 2:00

Strengthening of group's R&D team (99.72 KB)

Other

Download

08/10/09 - 2:00

2009 Financial calendar update (97.3 KB)

Financial Data

Download

05/10/09 - 2:00

Financial instruments to employees (27.08 KB)

Financial Data

Download

06/08/09 - 2:00

The BoD approves H1'09 results (214.79 KB)

Financial Data

Download

08/06/09 - 2:00

2009 Financial calendar update (97.33 KB)

Financial Data

Download

18/05/09 - 2:00

Financial instruments to employees (26.65 KB)

Financial Data

Download

10/04/09 - 2:00

Corporate Governance Report at December 2008. (97.57 KB)

Financial Data

Download

08/04/09 - 2:00

2009 Financial calendar update (103.88 KB)

Financial Data

Download

19/03/09 - 1:00

The BoD approves FY 2008 results (221.59 KB)

Financial Data

Download

20/02/09 - 1:00

Financial instruments to employees (26.39 KB)

Financial Data

Download

13/02/09 - 1:00

The BoD approves Q4'08 results (170.79 KB)

Financial Data

Download

28/01/09 - 1:00

2009 Financial calendar (93.96 KB)

Financial Data

Download

08/01/09 - 1:00

FDA clearance to five LIAISON products (96.84 KB)

Products Immunodiagnostic

Download

Newsroom press releases

Select year

Newsroom press category

The Board of Directors approves the Q3'13 Results (766.57 KB)

DiaSorin signes a 5-year agreement with Roche (432.42 KB)

DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)

DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)

DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)

The Board of Directors approves the results for the H1 '13 (386.67 KB)

DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)

DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)

DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)

The Board of Directors approves the results for Q1'13 (763.61 KB)

Compensation Commitee-Errata corrige (179.38 KB)

Shareholders' meeting approves FY Results 2012 (57.22 KB)

FDA approves the Aldosterone assay (439.58 KB)

DiaSorin signs an agreement with Seegene (243.64 KB)

The BoD approves FY 2012 results (477.24 KB)

Notification of changes in share capital (46.86 KB)

Notice availability By-Laws (36.87 KB)

Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)

Notification of changes in share capital (46.89 KB)

Notice availability By-Laws (139.13 KB)

The Board of Directors approves the results for the FY '12 (477.24 KB)

Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)

Financial instruments to employees (26.76 KB)

The BoD approves Q3'09 results (212.92 KB)

Strengthening of group's R&D team (99.72 KB)

2009 Financial calendar update (97.3 KB)

Financial instruments to employees (27.08 KB)

The BoD approves H1'09 results (214.79 KB)

2009 Financial calendar update (97.33 KB)

Financial instruments to employees (26.65 KB)

Corporate Governance Report at December 2008. (97.57 KB)

2009 Financial calendar update (103.88 KB)

The BoD approves FY 2008 results (221.59 KB)

Financial instruments to employees (26.39 KB)

The BoD approves Q4'08 results (170.79 KB)

2009 Financial calendar (93.96 KB)

FDA clearance to five LIAISON products (96.84 KB)

Price Sensitive